Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Nervous system paraneoplastic syndromes
MeSH D020361 - nervous system paraneoplastic syndromes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019636:
Neurodegenerative diseases
1 Company
1 Drug
$
Success rate
D010257:
Paraneoplastic syndromes
1 Company
1 Drug
$
Success rate
D009423:
Nervous system neoplasms
1 Company
1 Drug
$
Success rate
D020361:
Nervous system paraneoplastic syndromes
1 Company
1 Drug
$
Success rate
D009157:
Myasthenia gravis
55 Companies
8 Drugs
$
Success rate
D009188:
Transverse myelitis
30 Companies
1 Drug
$
Success rate
D020362:
Paraneoplastic cerebellar degeneration
0 Companies
0 Drugs
Success rate
D020363:
Limbic encephalitis
0 Companies
0 Drugs
Success rate
D020364:
Paraneoplastic polyneuropathy
0 Companies
0 Drugs
Success rate
D053578:
Opsoclonus-myoclonus syndrome
0 Companies
0 Drugs
Success rate
D060426:
Anti-n-methyl-d-aspartate receptor encephalitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use